Development of an Efficient Pd-Catalyzed Coupling Process for Axitinib
Organic Process Research & Development2013Vol. 18(1), pp. 266–274
Citations Over TimeTop 14% of 2013 papers
Brian P. Chekal, Steven M. Guinness, Brett M. Lillie, Robert W. McLaughlin, Charles W. Palmer, Ronald J. Post, Janice E. Sieser, Robert A. Singer, Gregory W. Sluggett, Rajappa Vaidyanathan, Gregory J. Withbroe
Abstract
The manufacturing process of axitinib (1) involves two Pd-catalyzed coupling reactions, a Migita coupling and a Heck reaction. Optimization of both of these pivotal bond-formation steps is discussed as well as the approach to control impurities in axitinib. Essential to the control strategy was the optimization of the Heck reaction to minimize formation of impurities, in addition to the development of an efficient isolation of crude axitinib to purge impurities.
Related Papers
- → Metallic Palladium in the Heck Reaction: Active Catalyst or Convenient Precursor?(2001)197 cited
- → Axitinib in the Treatment of Metastatic Renal Cell Carcinoma(2011)37 cited
- → Iminophosphine palladium(II) complexes: synthesis, characterization, and application in Heck cross‐coupling reaction of aryl bromides(2014)23 cited
- → Development and Scale up of Preparative HIC for the Purification of a Recombinant Therapeutic Protein(2005)29 cited
- → Metallic Palladium in the Heck Reaction: Active Catalyst or Convenient Precursor?(2001)2 cited